A large VC was evaluating an early stage startup that had built automated testing tools for software developers. The startup had a great pitch deck, a tech-savvy team, and happy early customers. But there is a big difference between pain, and screaming pain, and this VC asked our take as to where this company’s roadmap would land on that spectrum. CTOs from our braintrust reviewed the pitch deck, product demo and roadmap and reported back that the startup’s future state would only provide incremental improvements over the roadmaps of its better funded competitors. The investor gained peace of mind knowing that they were not missing out on the next big thing.
